Filter posts

Panelists ponder when the window will open

Panelists in this afternoon’s business roundtable “Window Shopping – The Buyer’s Perspective on Today’s IPO …

Healthcare reform: sustaining biotech innovation in a new world

The Eighth Annual BIO Investor Forum kicked off today with a plenary session on health …

Guest blogger post: The Lure of Translational Research

As a breast cancer advocate, I am seduced by the lure of translational research and …

Encouraging Louisiana to Partner with BIO

Louisiana is one of just a few states that do not yet have a BIO …

The Burrill Report Interview with Jim Greenwood

The Burrill Report’s Daniel Levine spoke with Jim Greenwood, president and CEO of BIO, about …

Industrial and Environmental Biotech in the Blogosphere

This week we start off with a United Nations report that urges caution on biofuels. …

Compounded Climate Accounting Errors

Timothy Searchinger, visiting scholar at Princeton University, Dan Kammen of the University of California Berkeley, …

Development continues for osteoporosis drug

Osteologix, Inc. (OLGX.OB) will continue the clinical development for its osteoporosis drug, NB S101 (strontium …

Oncolytics invests in private biotech company

Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) invested in British Canadian Biosciences Corp., a privately …

Podcast with Fast Forward's Tim Coetzee

Biotech Now’s Tracy Krughoff spoke with Dr. Tim Coetzee, president of Fast Forward, a subsidiary …